This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Two Part, Multi-Centre, Randomized, Placebo-Cont...
Clinical trial

A Two Part, Multi-Centre, Randomized, Placebo-Controlled, Double-Blind Study of TRK-170 for the Treatment of Crohn's Disease

Read time: 1 mins
Last updated:1st Jun 2011
The primary objective: Part A / To evaluate the effect of TRK-170 on mucosal healing as measured by Crohn's Disease Endoscopic Index of Severity (CDEIS) score based on ileocolonoscopy and use this evaluation to decide which dose(s) of TRK-170 should be used in Part B Part B / To evaluate the efficacy of TRK-170 in patients with active CD as measured by CDAI score
Category Value
Study start date 2011-06-01

View full details